Coloplast A/S Stock price

Equities

COLO B

DK0060448595

Medical Equipment, Supplies & Distribution

Delayed Nasdaq Copenhagen 11:59:35 2024-03-27 am EDT 5-day change 1st Jan Change
932.4 DKK +0.54% Intraday chart for Coloplast A/S -0.21% +20.78%
Sales 2024 * 27.22B 3.94B Sales 2025 * 29.59B 4.28B Capitalization 210B 30.33B
Net income 2024 * 5.32B 770M Net income 2025 * 6.21B 899M EV / Sales 2024 * 8.39 x
Net Debt 2024 * 18.88B 2.73B Net Debt 2025 * 17.59B 2.55B EV / Sales 2025 * 7.68 x
P/E ratio 2024 *
39.1 x
P/E ratio 2025 *
33.6 x
Employees 15,751
Yield 2024 *
2.22%
Yield 2025 *
2.41%
Free-Float 58.32%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.54%
1 week-0.21%
Current month+1.83%
1 month+1.61%
3 months+19.88%
6 months+25.02%
Current year+20.78%
More quotes
1 week
924.60
Extreme 924.6
938.00
1 month
904.60
Extreme 904.6
977.60
Current year
757.80
Extreme 757.8
977.60
1 year
689.20
Extreme 689.2
993.00
3 years
689.20
Extreme 689.2
1 194.00
5 years
677.60
Extreme 677.6
1 194.00
10 years
407.00
Extreme 407
1 194.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 54 07-12-31
Director of Finance/CFO 52 05-12-31
Chairman 65 87-12-31
Members of the board TitleAgeSince
Director/Board Member 76 68-09-30
Director/Board Member 59 17-11-30
Chairman 65 87-12-31
More insiders
Date Price Change Volume
24-03-27 932.4 +0.54% 174,742
24-03-26 927.4 -0.51% 120,503
24-03-25 932.2 +0.04% 108,908
24-03-22 931.8 +0.19% 87,361
24-03-21 930 -0.47% 215,857

Delayed Quote Nasdaq Copenhagen, March 27, 2024 at 11:59 am EDT

More quotes
Coloplast A/S specializes in the design, manufacturing, and marketing of disposable medical products. Net sales break down by family of products as follows: - hygiene products (44.6%): urine bags, plugs, urinary testing systems and sets, etc.; - ostomy care products (38.2%): bags and equipment used following intestinal operations; - wound care and skincare products (11.9%): wound dressings, bandages, creams and gels; - voice and respiratory care products (5.3%): voice prostheses for speaking, adhesives, laryngectomy cannulas for breathing, hands-free speaking devices, etc. Net sales are distributed geographically as follows: Denmark (1.3%), the United States (18.9%), the United Kingdom (13.7%), France (10.9%) and other (55.2%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
932.4 DKK
Average target price
897.3 DKK
Spread / Average Target
-3.76%
Consensus
  1. Stock
  2. Equities
  3. Stock Coloplast A/S - Nasdaq Copenhagen